Safety Assessment of Angioplasty Procedures
Safety Assessment of Angioplasty Procedures
Ischemic heart disease, or coronary heart disease, covers a set of pathologies due to
 insufficient oxygen supply to the myocardium due to the development of atherosclerosis in one
 or more coronary arteries. To evaluate the safety of angioplasty performed in patients
 operated on at La Rochelle Hospital, the rate of major adverse cardiac events (MACE) will be
 determined and compared with data from the literature.
The use of active stents for the treatment of coronary stenosis is currently the standard
 treatment in almost all types of coronary lesions. In percutaneous transluminal treatment of
 coronary lesions, balloon angioplasty and bare stents have not shown satisfactory results in
 the past. The so-called active drug-eluting balloon could represent a new therapeutic option
 for the treatment of de novo lesions.
Inclusion Criteria:

 -  Interventional revascularization of a coronary lesion,

 -  Member or beneficiary of a social security system,

 -  Informed of the study.

 Exclusion Criteria:

 -  Language barrier,

 -  Minor,

 -  Pregnant woman,

 -  Person under guardianship,

 -  Person deprived of his/her liberty,

 -  Refusal to participate.